Miromatrix Medical Inc.
MIRODelisted Dec 13, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001527096
Miromatrix Medical Inc. was delisted on Dec 13, 2023; its insiders filed their last Form 4 on Dec 13, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $8.78M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Miromatrix Medical Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +6 vs. Q3 2022
- Shares held
- 3.75M
- +223.9K (+6.4%) vs. Q3 2022
- Total value
- $11.2M
- −$4.23M (−27.4%) vs. Q3 2022
- New holders
- 7
- 8 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 32 | $8.78M |
| Q2 2023 | 32 | $11.6M |
| Q1 2023 | 31 | $11.1M |
| Q4 2022 | 28 | $11.2M |
| Q3 2022 | 22 | $15.4M |
| Q2 2022 | 22 | $12.9M |
| Q1 2022 | 21 | $12.6M |
| Q4 2021 | 22 | $14.5M |
| Q3 2021 | 19 | $22.0M |
| Q2 2021 | 21 | $39.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Miromatrix Medical Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 32 | $96 | 0.00% | +32 | New |
| Harbour Investments, Inc. | 38 | $114 | 0.00% | +38 | New |
| Wells Fargo & Company | 112 | $335 | 0.00% | +3+2.8% | Added |
| Advisor Group Holdings, Inc. | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,000 | $2.99K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,645 | $5.00K | 0.00% | +1,645 | New |
| Royal Bank of Canada | 2,000 | $6.00K | 0.00% | −71−3.4% | Reduced |
| HHM Wealth Advisors, LLC | 3,500 | $10.5K | 0.00% | +3,500 | New |
| Tower Research Capital LLC (TRC) | 9,024 | $27.0K | 0.00% | +5,412+149.8% | Added |
| US Bancorp | 10,000 | $29.9K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 11,036 | $33.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 15,169 | $45.4K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 19,739 | $59.0K | 0.00% | +19,739 | New |
| Commonwealth Equity Services, LLC | 26,669 | $79.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 30,017 | $89.8K | 0.00% | +5,800+24.0% | Added |
| BlackRock Inc. | 38,655 | $115.6K | 0.00% | +1,033+2.7% | Added |
| Envestnet Asset Management Inc | 48,036 | $143.6K | 0.00% | 00.0% | Unchanged |
| Legacy Wealth Asset Management, LLC | 50,536 | $151.1K | 0.06% | 00.0% | Unchanged |
| Merit Financial Group, LLC | 60,900 | $182.1K | 0.01% | +60,900 | New |
| Sweet Financial Partners, LLC | 135,112 | $404.0K | 0.12% | −136,056−50.2% | Reduced |
| Geode Capital Management, LLC | 139,581 | $417.0K | 0.00% | +2,847+2.1% | Added |
| Mayo Clinic | 191,622 | $573.0K | 0.30% | +191,622 | New |
| Gagnon Advisors, LLC | 229,802 | $687.1K | 0.46% | −149,618−39.4% | Reduced |
| RTW Investments, LP | 280,000 | $837.2K | 0.02% | 00.0% | Unchanged |
| G2 Investment Partners Management LLC | 426,762 | $1.28M | 0.38% | −58,438−12.0% | Reduced |
| First Light Asset Management, LLC | 534,656 | $1.60M | 0.15% | +18,649+3.6% | Added |
| Vanguard Group Inc | 635,155 | $1.90M | 0.00% | +205,864+48.0% | Added |
| Gagnon Securities LLC | 846,932 | $2.53M | 0.56% | +54,988+6.9% | Added |
| UBS Group AG | 0 | $0 | 0.00% | −3,964−100.0% | Sold out |